Sierra Oncology Inc (SRRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2016 | 12-2015 | 12-2014 | 12-2013 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 109,007 | 150,180 | 29,154 | 2,429 |
| Marketable Securities | N/A | N/A | 10,010 | N/A |
| TOTAL | $110,350 | $151,853 | $39,725 | $2,459 |
| Non-Current Assets | ||||
| PPE Net | 400 | 566 | 214 | 1 |
| Other Non-Current Assets | 223 | 349 | 626 | 0 |
| TOTAL | $623 | $915 | $840 | $1 |
| Total Assets | $110,973 | $152,768 | $40,565 | $2,460 |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 2,604 | 358 | 622 | 165 |
| Accrued Expenses | 5,121 | 7,016 | 1,473 | 733 |
| Other current liabilities | N/A | 23 | N/A | N/A |
| TOTAL | $7,725 | $7,397 | $2,095 | $898 |
| Non-Current Liabilities | ||||
| Long Term Debt | N/A | N/A | N/A | 412 |
| Other Non-Current Liabilities | 0 | 0 | 146,285 | 35,840 |
| TOTAL | $N/A | $N/A | $146,285 | $36,252 |
| Total Liabilities | $7,725 | $7,397 | $148,380 | $37,150 |
| Shareholders' Equity | ||||
| Shares Outstanding, K | N/A | 752 | N/A | N/A |
| Common Shares | 30 | 30 | 2 | 1 |
| Retained earnings | -582,054 | -534,187 | -107,807 | -34,691 |
| Other shareholders' equity | 0 | 0 | -10 | 0 |
| TOTAL | $103,248 | $145,371 | $-107,815 | $-34,690 |
| Total Liabilities And Equity | $110,973 | $152,768 | $40,565 | $2,460 |